Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
Holding ARTV?
Track your performance easily

Artiva Biotherapeutics, Inc. (ARTV) Income Statement

11 Followers

Artiva Biotherapeutics, Inc. Income Statement

Last quarter (Q ), Artiva Biotherapeutics, Inc.'s total revenue was $251.00K, an increase of Infinity% from previous quarter. In Q, Artiva Biotherapeutics, Inc.'s net income was $-13.96M. See Artiva Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
$ 251.00K$ 33.49M$ 4.93M
Cost of Revenue
---
Gross Profit
$ 251.00K$ 33.49M$ 4.93M
Operating Expense
$ 14.74M$ 64.16M$ 64.76M
Operating Income
$ -14.49M$ -30.67M$ -59.83M
Net Non Operating Interest Income Expense
$ 650.00K$ 2.54M$ 1.29M
Other Income Expense
$ 121.00K$ 512.00K$ 200.00K
Pretax Income
$ -13.96M$ -28.65M$ -58.73M
Tax Provision
-$ 72.00K$ 53.00K
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -13.96M$ -28.72M$ -58.79M
Basic EPS
$ -1.49$ -35.78$ -76.67
Diluted EPS
$ -1.49$ -35.78$ -76.67
Basic Average Shares
$ 809.76K$ 802.75K$ 766.72K
Diluted Average Shares
$ 809.76K$ 802.75K$ 766.72K
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 14.74M$ 64.16M$ 64.76M
Net Income From Continuing And Discontinued Operation
$ -13.96M$ -28.72M$ -58.79M
Normalized Income
$ -13.82M$ -21.06M$ -43.17M
Interest Expense
---
EBIT
$ -13.96M$ -28.65M$ -58.73M
EBITDA
$ -13.38M$ -26.38M$ -57.58M
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis